Neuroinflammation and proteostasis are modulated by endogenously biosynthesized neuroprotectin D1

Molecular Neurobiology

Volumn 46, Issue 1, 2012, Pages 221-226

  Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

APP; Ataxin 1; Bcl 2 proteins; CAG repeats; Docosahexaenoic acid; Epilepsy; Huntingtin; Huntington's disease; Misfolding; Retinal degenerations .Alzheimer's disease

Indexed keywords

DOCOSAHEXAENOIC ACID; NEUROPROTECTIN D1; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; FATTY ACID SYNTHESIS; HOMEOSTASIS; HUMAN; NERVE CELL NETWORK; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS;

EID: 84868132516     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8322-5     Document Type: Article

References (33)

1. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204-1222
2. Kim D, Tsai LH (2009) Bridging physiology and pathology in AD. Cell 137(6):997-1000
3. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63(3):287-303
4. Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461(7266):916-922
5. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegenration. Cell 140(6):918-934
6. Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous system parenchyma. Nature 468(7321):253-262
7. Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71(1):35-48
8. Bazan NG, Musto AE, Knott EJ (2011) Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol 44(2):216-222
9. Kim HY, Spector AA, Xiong ZM (2011) A synaptogenic amide Ndocosahexaenoylethanolamide promotes hippocampal development. Prostglandins Other Lipid Mediat 96(1-4):114-120
10. Rapoport SI, Ramadan E, Basselin M (2011) Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an invivo biomarker of brain DHA metabolism and neurotransmission. Prostglandins Other Lipid Mediat 96(1-4):109-113
11. Hashimoto M, Hossain S (2011) Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J Pharmacol Sci 116(2):150-162
12. Calon F (2011) Omega-3 polyunsaturated fatty acid in Alzheimer's disease: key questions and partial answers. Curr Alzheimer Res 8 (5):470-478
13. Astarita G, Piomelli D (2011) Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease. Prostaglandins Leukot Essent Fatty Acids 85(5):197-203
14. Simopoulos AP (2011) Evolutionary aspects of diet: the omega-6/ omega-3 ratio and the brain. Mol Neurobiol 44(2):203-215
15. Cole GM, Ma QL, Frautschy SA (2010) Dietary fatty acids and the aging brain. Nutr Rev 68(suppl2):102-111
16. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia-reperfusionmediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278(44):43807-43817 (Pubitemid 37346009)
17. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 101:8491-8496 (Pubitemid 38736602)
18. Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase-and PPARγ-mediated mechanisms in Alzheimer's disease models. PLoS One 6(1): e15816
19. Calandria JM, Mukherjee PK, de Rivero Vaccari JC, Zhu M, Petasis NA, Bazan NG (2012) Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1. J Biol Chem 287(28):23726-23739
20. Musto AE, Gjorstrup P, Bazan NG (2011) The omega-3 fatty acidderived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis. Epilepsia 52(9):1601-1608
21. Belayev L, Eady TN, Khotorova L, Atkins KD, Obenaus A, Cordoba M, Vaquero JJ, Alvarez-Builla J, Bazan NG (2011) Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke. Transl Stroke Res 3(1):154-163
22. Mukherjee PK, Marcheselli VL, de Rivero Vaccari JC, Gordon WC, Jackson FE, Bazan NG (2007) Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc Natl Acad Sci USA 104(32):13158-13163 (Pubitemid 351737609)
23. Bazan NG, Molina MF, Gordon WC (2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 31:321-351
24. Zoghbi H.Y., Bear M.F. (2012) Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 4, (3).
25. Zoghbi HY, Bear MF (2012) Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol 4(3) 25. Zoghbi HY, Orr HT (2009) Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type-1. J Biol Chem 284(12):7425-7429
26. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115(10):2774-2783 (Pubitemid 41434404)
27. Astarita G, Jung KM, Berchtold NC, Nguyen VQ, Gillen VQ, Gillen DL, Head E, Cotman CW, Piomelli D (2010) Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 5(9):e12538
28. Calandria JM, Bazan NG (2010) Neuroprotectin D1 modulates the induction of pro-inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress. Adv Exp Med Biol 664:663-670
29. Antony R, Lukiw WJ, Bazan NG (2010) Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival. J Biol Chem 285(24):18301-18308
30. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464(7288):529-535
31. Sheets KG, Zhou Y, Ertel MK, Knott EJ, Regan CE Jr, Elison JR, Gordon WC, Gjorstrup P, Bazan NG (2010) Neuroprotectin D1attenuates laser-induced choroidal neovascularization in mouse. Mol Vis 2(16):320-329
32. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148(5):852-871
33. Belayev L et al (2011) Docosahexaenoic acid therapy of experimental ischemic stroke. Translational Stroke Research 2:33-41